Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
28.66
+0.84 (3.02%)
At close: Mar 9, 2026, 4:00 PM EDT
29.21
+0.55 (1.92%)
After-hours: Mar 9, 2026, 6:24 PM EDT
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $3.07 billion as of March 9, 2026. Its market cap has increased by 19.81% in one year.
Market Cap
3.07B
Enterprise Value
2.56B
1-Year Change
19.81%
Ranking
Category
Stock Price
$28.66
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $3.07B, an increase of 303.95%. That is a compound annual growth rate of 32.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.98B | 13.59% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alumis | 3.35B |
| Spyre Therapeutics | 3.15B |
| Denali Therapeutics | 3.12B |
| Tarsus Pharmaceuticals | 3.12B |
| Arcutis Biotherapeutics | 2.98B |
| Catalyst Pharmaceuticals | 2.96B |
| IDEAYA Biosciences | 2.91B |
| Viridian Therapeutics | 2.90B |